Stay updated on Sage-217 Efficacy in MDD Clinical Trial
Sign up to get notified when there's something new on the Sage-217 Efficacy in MDD Clinical Trial page.

Latest updates to the Sage-217 Efficacy in MDD Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedBiogen is now listed as the sponsor following a transfer from Sage Therapeutics, and the study results were posted (Results First Posted 2023-12-05).SummaryDifference0.3%

- Check16 days agoNo Change Detected
- Check38 days agoChange DetectedMajor update: adds current operating status notice and links for NIH Clinical Center, and bumps version to v3.2.0, replacing the old v3.1.0.SummaryDifference3%

- Check45 days agoChange DetectedMajor change: page now shows Revision: v3.1.0 and removes several drug-safety topics; indicates a content reorganization with updated versioning rather than new substantive information in the deleted areas.SummaryDifference0.3%

- Check59 days agoChange DetectedVersion updated from v3.0.1 to v3.0.2. The 'Back to Top' element was removed.SummaryDifference0.2%

- Check66 days agoChange DetectedThe web page has been updated from version 3.0.0 to 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.SummaryDifference0.2%

- Check73 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location, as well as new drug information related to Zuranolone and topics on drug safety and counterfeit drugs. However, previous location details and certain drug classifications have been removed.SummaryDifference2%

Stay in the know with updates to Sage-217 Efficacy in MDD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sage-217 Efficacy in MDD Clinical Trial page.